- The Fluorosome Company - http://www.fluorosome.com -
Continuously Improving Through Innovation
Welcome to the Fluorosome Company. The Fluorosome Company develops and manufactures liposome-based fluorescence detection systems – Fluorosomes® – for applications in drug discovery and related fields. Utilizing the Fluorosome® platform we are continuously expanding our technology to develop new tools for “ADMET” studies in drug discovery.
The basic platform – Fluorosome®-trans – measures passive drug diffusion through the membrane bilayer, yielding the property “membrane permeability”, which is predictive of tissue absorption e.g. oral absorption of a drug.
Our flagship product is the Fluorosome®-trans-pgp assay. This high throughput inhibition assay is an innovative “stand alone” platform for characterizing P-glycoprotein/drug interactions. The P-glycoprotein is a key drug efflux pump responsible for poor oral drug absorption and penetration into the brain, as well as multi-drug resistance in tumors. Unlike older vesicle assay systems formed from heterogeneous membrane fragments, Fluorosome-trans-pgp consists of highly purified functional P-glycoprotein in pure lipid vesicles.
Article printed from The Fluorosome Company: http://www.fluorosome.com
URL to article: http://www.fluorosome.com/
Click here to print.
Copyright © 2011 The Fluorosome Company. All rights reserved.